1-3 of 3
Elizabeth C Matheson
Close
Sort by
Journal Articles

RAS Pathway Mutations Are Highly Prevalent In Relapsed Childhood Acute Lymphoblastic Leukaemia, Are Frequently Relapse-Drivers and Confer Sensitivity To MEK Inhibition

Julie Irving, PhD, Elizabeth C. Matheson, MPhil, Lynne Minto, Helen Blair, PhD, Marian Case, MSc, Christina Halsey, MD, PhD, Isabella Swidenbank, MRes, Frida Ponthan, PhD, Renate Kirschner-Schwabe, PhD, Stefanie Groeneveld-Krentz, MSc, Jana Hof, MSc, James Allan, PhD, Christine J. Harrison, PhD, Josef Vormoor, MD, Arend Stackelberg, MD, Cornelia Eckert, PhD
Journal: Blood
Blood (2013) 122 (21): 823.
https://doi.org/10.1182/blood.V122.21.823.823
Published: 2013
Journal Articles

Quantitative Proteomic Analysis Reveals Maturation As a Mechanism Underlying Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia and PAX5 As a Re-Sensitising Therapeutic Target

Lindsay Nicholson, PhD, Caroline Evans, PhD, Elizabeth C Matheson, MPhil, Lynne Minto, Christopher Keilty, Claire Schwab, Christine J Harrison, PhD, FRCPath, Andrew G. Hall, MB, BS, FRCPath, FRCP, PhD, Christopher Redfern, PhD, Anthony Whetton, PhD, Julie Irving, PhD
Journal: Blood
Blood (2011) 118 (21): 1411.
https://doi.org/10.1182/blood.V118.21.1411.1411
Published: 2011
Journal Articles

Cellular Response to Cytarabine Is Modulated by the DNA Mismatch Repair Pathway: Implications for Treatment of Acute Myeloid Leukemia

Sarah E Fordham, Elizabeth C Matheson, Kathryn Scott, Julie Irving, James M Allan
Journal: Blood
Blood (2010) 116 (21): 1819.
https://doi.org/10.1182/blood.V116.21.1819.1819
Published: 2010